Cognitive Stimulation Interventions for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review and Meta-Analysis.

IF 4.4 2区 医学 Q1 ONCOLOGY
Cancers Pub Date : 2025-09-14 DOI:10.3390/cancers17183001
Macarena C Cáceres, Miguel Ángel Martín-Parrilla, Jesús Montanero-Fernández, Aitana Santos-Fernández, Casimiro Fermín López-Jurado, Noelia Durán-Gómez
{"title":"Cognitive Stimulation Interventions for Chemotherapy-Related Cognitive Impairment in Breast Cancer Patients: A Systematic Review and Meta-Analysis.","authors":"Macarena C Cáceres, Miguel Ángel Martín-Parrilla, Jesús Montanero-Fernández, Aitana Santos-Fernández, Casimiro Fermín López-Jurado, Noelia Durán-Gómez","doi":"10.3390/cancers17183001","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background</b>: A considerable proportion of breast cancer (BC) patients experience chemotherapy-related cognitive impairment (CRCI) and other symptoms even after the completion of treatment. The persistence of CRCI throughout the oncological process highlights the need for routine assessment of its severity, impact on quality of life, and the effectiveness of interventions aimed at addressing it. <b>Objectives</b>: To analyse the effectiveness of cognitive stimulation interventions on CRCI in BC patients and to identify the characteristics of such interventions, including the most appropriate timing for their implementation, the most suitable techniques, and their duration. <b>Methodology</b>: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. Randomized controlled trials published between 1 January 2020 and 31 December 2024 were searched across three electronic databases. Studies involving cognitive stimulation interventions for the management of CRCI in BC patients were included. <b>Results</b>: A total of 12 eligible studies were identified for the systematic review and 10 for the meta-analysis. The review revealed a wide range of cognitive stimulation interventions, differing in techniques, duration, format, and timing of implementation. Group-based therapies lasting between 6 and 12 weeks predominated, with cognitive outcomes primarily assessed using the FACT-Cog scale. The meta-analysis demonstrated a moderate positive effect of cognitive stimulation interventions on cognitive functioning in BC patients (d = 0.59), although not statistically significant (<i>p</i> = 0.07), and showed high heterogeneity across studies (I<sup>2</sup> = 93%). <b>Conclusions</b>: Cognitive stimulation interventions show potential benefits in improving cognitive functioning in BC patients following chemotherapy. However, the high methodological heterogeneity limits the strength of the evidence. Further research is needed to develop standardized and personalized early intervention protocols.</p>","PeriodicalId":9681,"journal":{"name":"Cancers","volume":"17 18","pages":""},"PeriodicalIF":4.4000,"publicationDate":"2025-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12468572/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancers","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/cancers17183001","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: A considerable proportion of breast cancer (BC) patients experience chemotherapy-related cognitive impairment (CRCI) and other symptoms even after the completion of treatment. The persistence of CRCI throughout the oncological process highlights the need for routine assessment of its severity, impact on quality of life, and the effectiveness of interventions aimed at addressing it. Objectives: To analyse the effectiveness of cognitive stimulation interventions on CRCI in BC patients and to identify the characteristics of such interventions, including the most appropriate timing for their implementation, the most suitable techniques, and their duration. Methodology: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. Randomized controlled trials published between 1 January 2020 and 31 December 2024 were searched across three electronic databases. Studies involving cognitive stimulation interventions for the management of CRCI in BC patients were included. Results: A total of 12 eligible studies were identified for the systematic review and 10 for the meta-analysis. The review revealed a wide range of cognitive stimulation interventions, differing in techniques, duration, format, and timing of implementation. Group-based therapies lasting between 6 and 12 weeks predominated, with cognitive outcomes primarily assessed using the FACT-Cog scale. The meta-analysis demonstrated a moderate positive effect of cognitive stimulation interventions on cognitive functioning in BC patients (d = 0.59), although not statistically significant (p = 0.07), and showed high heterogeneity across studies (I2 = 93%). Conclusions: Cognitive stimulation interventions show potential benefits in improving cognitive functioning in BC patients following chemotherapy. However, the high methodological heterogeneity limits the strength of the evidence. Further research is needed to develop standardized and personalized early intervention protocols.

认知刺激干预化疗相关认知障碍乳腺癌患者:系统回顾和荟萃分析。
背景:相当比例的乳腺癌(BC)患者即使在完成治疗后也会出现化疗相关认知障碍(CRCI)和其他症状。CRCI在整个肿瘤过程中持续存在,这突出了对其严重程度、对生活质量的影响以及针对其干预措施的有效性进行常规评估的必要性。目的:分析认知刺激干预对BC患者CRCI的有效性,并确定此类干预的特征,包括实施的最合适时机、最合适的技术和持续时间。方法:根据PRISMA指南进行系统评价和荟萃分析。在三个电子数据库中检索了2020年1月1日至2024年12月31日发表的随机对照试验。包括认知刺激干预治疗BC患者CRCI的研究。结果:共有12项符合条件的研究被纳入系统评价,10项符合条件的研究被纳入meta分析。这篇综述揭示了认知刺激干预的广泛范围,在技术、持续时间、形式和实施时间上有所不同。持续6至12周的小组治疗占主导地位,认知结果主要使用FACT-Cog量表进行评估。meta分析显示,认知刺激干预对BC患者的认知功能有中等程度的积极影响(d = 0.59),尽管没有统计学意义(p = 0.07),并且在研究中显示出高度异质性(I2 = 93%)。结论:认知刺激干预在改善化疗后BC患者的认知功能方面显示出潜在的益处。然而,方法的高度异质性限制了证据的强度。需要进一步的研究来制定标准化和个性化的早期干预方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancers
Cancers Medicine-Oncology
CiteScore
8.00
自引率
9.60%
发文量
5371
审稿时长
18.07 days
期刊介绍: Cancers (ISSN 2072-6694) is an international, peer-reviewed open access journal on oncology. It publishes reviews, regular research papers and short communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信